Загрузка...
Complete resolution of erythrodermic psoriasis with first-line apremilast monotherapy
Erythrodermic psoriasis (EP) is the most serious type of psoriasis with high morbidity and mortality. First-line recommended therapies for EP, cyclosporine and infliximab have significant adverse effects. Cyclosporine increases the risk of hypertension, leucopenia, infections and renal failure. Infl...
Сохранить в:
| Опубликовано в: : | BMJ Case Rep |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6357920/ https://ncbi.nlm.nih.gov/pubmed/30709830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-226959 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|